We’re pleased to share that endogene.bio has been awarded the Sanofi Golden Ticket at BioLabs.
Following our selection for the DayOne Accelerator 2026, this award marks another step forward as we advance our uterine health platform and strengthen our engagement with the life sciences community and major pharmaceutical companies.
We thank Sanofi and BioLabs for their confidence in our work and look forward to contributing to the BioLabs community.
About endogene.bio
endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.
